Two AI-driven disruptors, one biotech-focused, one software-first, post double-digit growth but diverge sharply on risk, cash flow, and valuation.
23don MSN
Recursion Pharmaceuticals Just Hit a 52-Week Low. Is This Former Nvidia Holding a Smart Buy Now?
The stock looks cheap, but appearances can be deceiving.
The maker of Claude wants AI labs, including itself, to prepare for a coordinated slowdown if models begin building their own ...
Christopher Gibson, Co-Founder and CEO, announced, "beginning January 1, the amazing Najat Khan is going to take over the role of CEO, President and Director of Recursion." Gibson will transition to ...
Combinatorial optimization plays a crucial role in many industrial applications. While classical computing often struggles with complex instances, quantum optimization emerges as a promising ...
Building a model capable of RSI would require automating a range of specialist tasks currently carried out by humans. At ...
The cognitive processes driving social media use could be key to understanding social media’s impact. Here, the authors develop a computational model of real-world social media behaviour, identifying ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results